A Case of Locally Advanced, Unresectable Pancreatic Cancer with Superior Mesenteric Artery Invasion Treated with FOLFIRINOX plus Radiation Therapy, followed by Conversion Surgery

We report a case of a woman in her 70s who underwent conversion surgery after FOLFIRINOX, followed by radiation therapy for initially locally advanced unresectable pancreatic cancer. She visited her local doctor with a chief complaint of upper abdominal pain. Contrast-enhanced CT scan of the abdomen...

Full description

Saved in:
Bibliographic Details
Published inGan to kagaku ryoho Vol. 50; no. 8; p. 929
Main Authors Tani, Hiroki, Kato, Hiroyuki, Asano, Yukio, Ito, Masahiro, Arakawa, Satoshi, Shimura, Masahiro, Koike, Daisuke, Ochi, Takayuki, Kamio, Kenshiro, Kawai, Toki, Yasuoka, Hironobu, Higashiguchi, Takahiko, Kunimura, Yoshiki, Horiguchi, Kazuma, Nagata, Hidetoshi, Kondo, Yuka, Kato, Yutaro, Hanai, Tsunekazu, Sato, Harunobu, Horiguchi, Akihiko
Format Journal Article
LanguageJapanese
Published Japan 01.08.2023
Subjects
Online AccessGet more information

Cover

Loading…
More Information
Summary:We report a case of a woman in her 70s who underwent conversion surgery after FOLFIRINOX, followed by radiation therapy for initially locally advanced unresectable pancreatic cancer. She visited her local doctor with a chief complaint of upper abdominal pain. Contrast-enhanced CT scan of the abdomen revealed an irregular mass invading the superior mesenteric artery, and the first and second jejunal arteries(>180°)in the pancreatic uncinate region. Based on imaging, she was diagnosed as UR-LA(sm), cT4N0M0, cStage Ⅲ pancreatic cancer, and underwent 5 courses of modified FOLFIRINOX. Radiation therapy of 50.4 Gy was added for local control, and CA19-9 decreased from 394.1 U/mL to 10.5 U/mL. The treatment effect was judged as RECIST: partial response. The tumor was considered to be potentially curative, and a subtotal stomach preserving pancreaticoduodenectomy was performed 8 months after the initial treatment. The tumor was found to be 3× 2 mm in size, pStage ⅠA, R0, and the response to preoperative chemotherapy: Evans Grade Ⅲ. The patient is alive at 5 months postoperatively without recurrence.
ISSN:0385-0684